1. Liu, Aimei, Zhou, Kaixiang, Martínez, María Aránzazu, Anadón, Arturo, Ares, Irma. 2021. A "Janus" face of the RASSF4 signal in cell fate. In Journal of cellular physiology, 237, 466-479. doi:10.1002/jcp.30592. https://pubmed.ncbi.nlm.nih.gov/34553373/
2. De Smedt, Eva, Maes, Ken, Verhulst, Stefaan, Moreaux, Jérôme, De Bruyne, Elke. 2017. Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression. In Cancer research, 78, 1155-1168. doi:10.1158/0008-5472.CAN-17-1544. https://pubmed.ncbi.nlm.nih.gov/29259009/
3. Han, Yong, Dong, Qianze, Hao, Jie, Zheng, Xiaoying, Wang, Enhua. 2015. RASSF4 is downregulated in nonsmall cell lung cancer and inhibits cancer cell proliferation and invasion. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 37, 4865-71. doi:10.1007/s13277-015-4343-9. https://pubmed.ncbi.nlm.nih.gov/26526576/
4. Zhang, Minglei, Wang, Dapeng, Zhu, Tongtong, Yin, Ruofeng. . RASSF4 Overexpression Inhibits the Proliferation, Invasion, EMT, and Wnt Signaling Pathway in Osteosarcoma Cells. In Oncology research, 25, 83-91. doi:10.3727/096504016X14719078133447. https://pubmed.ncbi.nlm.nih.gov/28081736/
5. Cui, Sheng-Hai, Hu, Xiao-Di, Yan, Yan. 2021. Wnt/β-catenin signaling pathway participates in the effect of miR-626 on oral squamous cell carcinoma by targeting RASSF4. In Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 50, 1005-1017. doi:10.1111/jop.13216. https://pubmed.ncbi.nlm.nih.gov/34121238/
智鼠故事 
